Partner
Mark Nowakowski
Venture Partner, Phase Two Ventures
- Firm
- Phase Two Ventures
- Title
- Venture Partner
- Role
- Venture partner
- Known as
- Investor
Claim, correct or request removal
Record updated 21 September 2026
About
Mark has over 30 years of experience in molecular diagnostics and immunodiagnostics. He is a leader in lyophilization technologies and microchannel diagnostic cartridge designs, and is currently CTO and Board Member of Argonaut Manufacturing. He founded and grew Lyogen before its acquisition by Argonaut, and previously worked at Hybritech, Biosite Diagnostics, FMC BioProducts, and Mesa Biotech.
Is this you? Remove my profile
Loading relationship preview